Cargando…
Extremely high doses of radioiodine required for treatment of Graves’ hyperthyroidism: a case report
INTRODUCTION: Radioactive iodine ((131)I) is widely prescribed for treatment of Graves’ disease. A dose of 370 to 555 MBq (10 to 15 mCi) is usually enough, but reports of improved remission rates with single doses up to 20-30 mCi, and 38.5 mCi at most, exist. CASE PRESENTATION: A 53-year-old male pa...
Autores principales: | Neto, Arnaldo Moura, Tambascia, Marcos Antonio, Brunetto, Sergio, Ramos, Celso Dario, Zantut-Wittmann, Denise Engelbrecht |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Cases Network Ltd
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2769445/ https://www.ncbi.nlm.nih.gov/pubmed/19918435 http://dx.doi.org/10.4076/1757-1626-2-8479 |
Ejemplares similares
-
Value of Infrared Thermography Camera Attached to a Smartphone for Evaluation and Follow-up of Patients with Graves' Ophthalmopathy
por: Minatel Riguetto, Cínthia, et al.
Publicado: (2019) -
Fixed 30 mCi (1110 MBq) (131)I-iodine therapy in autonomously functioning nodules: Single toxic nodule as a predictive factor of success
por: Pereira, Lívia Stela Bueno, et al.
Publicado: (2021) -
Interplay Between Thyroid Hormone Status and Pulmonary Hypertension in Graves’ Disease: Relevance of the Assessment in Thyrotoxic and Euthyroid Patients
por: Araruna, Larisse Vieira Mendes, et al.
Publicado: (2022) -
Risk Factors Associated with Benign and Malignant Thyroid Nodules in Autoimmune Thyroid Diseases
por: Lima, Priscila Carneiro Moreira, et al.
Publicado: (2013) -
Abnormalities of Thyroid Hormone Metabolism during Systemic Illness: The Low T3 Syndrome in Different Clinical Settings
por: Moura Neto, Arnaldo, et al.
Publicado: (2016)